Dopamine-2 Receptor Antagonist [EPC]

7798 reported adverse events

Drugs of this class: DROPERIDOL AMISULPRIDE

These side effects are most commonly reported by patients taking drugs of the Dopamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 933
1 DRUG INTERACTION 579
2 WEIGHT INCREASED 448
3 TOXICITY TO VARIOUS AGENTS 443
4 NEUTROPENIA 418
5 OFF LABEL USE 404
6 SCHIZOPHRENIA 339
7 AKATHISIA 334
8 LEUKOPENIA 324
9 EXTRAPYRAMIDAL DISORDER 323
See all common reactions for Dopamine-2 Receptor Antagonist [EPC]

Drugs of the Dopamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 190 0.2750
1 DISINHIBITION 172 0.1068
2 ANTIPSYCHOTIC DRUG LEVEL DECREASED 55 0.1036
3 NAIL BED INFLAMMATION 28 0.0878
4 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 57 0.0640
5 MONOCYTOSIS 31 0.0499
6 ANTIPSYCHOTIC DRUG LEVEL INCREASED 139 0.0493
7 NASAL MUCOSAL DISORDER 27 0.0463
8 SCHIZOAFFECTIVE DISORDER 73 0.0409
9 THERAPEUTIC PRODUCT EFFECT VARIABLE 148 0.0381
See all enriched reactions for Dopamine-2 Receptor Antagonist [EPC]